Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of an Antiviral Drug (Valaciclovir) in the Treatment of Generalized Periodontitis (Stage III or IV and Grade A, B or C): Prospective, Randomized and Double Blind Clinical Trial

NCT05902208 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nice as lead sponsor.

NCT NCT05902208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05902208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of an Antiviral Drug (Valaciclovir) in the Treatment of Generalized Periodontitis (Stage III or IV and Grade A, B or C): Prospective, Randomized and Double Blind Clinical Trial
Lead sponsor
Centre Hospitalier Universitaire de Nice
Phase
Phase 3
Overall status
Unknown status
Start date
February 5, 2024
Completion date
May 31, 2026
Enrollment
142 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

periodontitis chronic generalized severe